US Stocks
/
Talphera, Inc. Share Price

Talphera, Inc. Share Price

NASDAQ: TLPH | Micro Cap
$1.21
-$0.03 (-2.82%) Last updated on 29 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Talphera, Inc. Stock Performance

Open
$1.23
Prev. Close
$1.24
Circuit Range
N/A
Day Range
$1.21 - $1.23
Year Range
$0.51 - $1.55
Volume
1,788
Average Traded
$1.21

Talphera, Inc. Share Price Today

As of 29 August 2026, Talphera, Inc.'s share price is $1.21. The stock opened at $1.23, compared to its previous close of $1.24. During today's trading session, Talphera, Inc.'s share price traded between $1.21 and $1.23, with an average price of $1.22. Over the past 52 weeks, the stock has recorded a high of $1.55 and a low of $0.51. In terms of performance, Talphera, Inc.'s share price has risen by 33.00% over the last six months and is up 123.15% on a year-on-year basis.

Talphera, Inc. Share Price Chart

$1.21$1.23
L
Show Current Price
H

Talphera, Inc. Stock Fundamentals & Key Indicators

Market Cap
$51.10M
PE Ratio (TTM)
-3.54
Dividend Yield
N/A
EPS (TTM)
$-0.34
Revenue (TTM)
$28000.00
Return On Equity (TTM)
-84.31%
Profit Margin
-51296.43%
Debt to Equity
0.22
Quarterly Earnings Growth YoY
-32.30%

Talphera, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$0.00$0.00$27000.00$0.00$1000.00
Net Profit-$3.95M-$3.83M-$3.35M-$2.59M-$3.49M-$4.44M
Net Profit MarginN/AN/AN/A-9603.70%N/A-443600.00%
Income ChangeN/A3.21%12.39%22.67%-34.55%-27.14%

Talphera, Inc. Annual Profit & Loss

All figures in USD

Particulars20232025
Revenue$651000.00$28000.00
Net Profit-$10.29MN/A
Net Profit Margin-1580.18%N/A
Income ChangeN/AN/A

About Talphera, Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.

Talphera, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.28
$1.23
-6.49%
Jul 2026
$1.01
$1.31
+26.57%
Jun 2026
$0.81
$1.03
+27.31%
May 2026
$0.93
$0.81
-10.66%
Apr 2026
$0.79
$0.91
+21.17%
Mar 2026
$0.89
$0.75
-17.11%
Feb 2026
$0.93
$0.91
-6.11%
Jan 2026
$1.11
$0.96
-14.22%
Dec 2025
$1.29
$1.13
-16.04%
Nov 2025
$1.39
$1.34
+2.29%
Oct 2025
$0.90
$1.31
+42.39%
Sep 2025
$0.53
$0.92
+70.37%

TLPH Share Price FAQs

What is Talphera, Inc. share price today?

chevron-up
Talphera, Inc. share price today is $1.21 as on August 29, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Talphera, Inc. stock?

chevron-up
The 52 week high of Talphera, Inc. stock is $1.55, while the 52 week low is $0.51 as of 29 Aug '26.

What is TLPH's market capitalisation today?

chevron-up
TLPH market capitalisation is $51.10M as of August 29, 2026, at 6:01 pm IST.

What is TLPH's net income for the last quarter?

chevron-up
TLPH's net income for the last quarter is -0.00B USD.

What is the 5 year returns of TLPH?

chevron-up
The 5 year returns of TLPH is -94.62% as on 29 Aug '26.

What is the high & low stock price of TLPH today?

chevron-up
TLPH stock price hit a high of $1.23 and low of $1.21 as of 29 Aug '26.

Can I buy TLPH shares in India?

chevron-up
Yes. You can buy TLPH in India by opening an international trading account.